Immediate Impact
32 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Recent progress of CDK4/6 inhibitors’ current practice in breast cancer
2024 Standout
Works of Faye Su being referenced
Abstract GS2-00: Correlative analysis of overall survival by intrinsic subtype across the MONALEESA-2, -3, and -7 studies of ribociclib + endocrine therapy in patients with HR+/HER2− advanced breast cancer
2022
Abstract PD2-08: Gene expression analysis and association with treatment response in postmenopausal patients with hormone receptor-positive, HER2-negative advanced breast cancer in the MONALEESA-3 study
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Faye Su | 127 | 115 | 53 | 13 | 156 | |
| Lori Marini | 91 | 124 | 69 | 9 | 185 | |
| Manuel Ramos Vázquez | 91 | 128 | 55 | 18 | 207 | |
| Xu-Shan Sun | 72 | 114 | 22 | 11 | 172 | |
| Isabel Echavarría | 45 | 78 | 42 | 14 | 129 | |
| Susana Bezares | 54 | 98 | 23 | 17 | 174 | |
| Paz J. Vellanki | 106 | 151 | 48 | 12 | 227 | |
| Anke Schlenska‐Lange | 56 | 66 | 58 | 9 | 171 | |
| Míriam Arumí | 79 | 112 | 47 | 12 | 169 | |
| Isabel Mayayo‐Peralta | 66 | 73 | 34 | 11 | 171 | |
| Jesús Corral Jaime | 109 | 105 | 17 | 15 | 171 |
All Works
Loading papers...